Your browser doesn't support javascript.
loading
Corrigendum to "Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy" Biomed. Pharmacother. 171 (2024) 116152.
You, Xiangyun; Zhu, Chunming; Yu, Puguang; Wang, Xia; Wang, Yibing; Wang, Jiahe; Yu, Junfeng; Wang, Kefeng.
Affiliation
  • You X; Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China; Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China.
  • Zhu C; Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, China.
  • Yu P; Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
  • Wang X; Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
  • Wang Y; Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: yibing_wang2015@126.com.
  • Wang J; Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: wangjiaheanglee@126.com.
  • Yu J; Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China. Electronic address: 574960333@qq.com.
  • Wang K; Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: 20081246@cmu.edu.cn.
Biomed Pharmacother ; 173: 116430, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38485617

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomed Pharmacother Year: 2024 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomed Pharmacother Year: 2024 Document type: Article Affiliation country: China